OpenVSafe by OpenVAERS
Search V-safe

3D9-33410-76397

3 vaccinations 2 coded responses 21 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
146 / NY
Registered
2021-01-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
77U-78098-20677 Child or adolescent in my care · Female · 2022-06-25

Timeline

  1. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-12
    Registered in v-safe
  3. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-12
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None · Be unable to do your normal daily activities
    Adult check-in
  5. 2021-01-12
    Report sent to call center — day 0, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  6. 2021-01-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness
    Free text: Supraclavicular and axillary painful lymphadenopathy
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-07-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-09-27
    Dose 3 — Pfizer-BioNTech
  14. 2021-09-29
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Lymph node swelling
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-09-30
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  16. 2021-10-01
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  17. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  18. 2021-10-03
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  19. 2021-10-04
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  20. 2021-10-11
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  21. 2021-10-18
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  22. 2021-10-25
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  23. 2021-11-01
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  24. 2021-11-08
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  25. 2021-12-27
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  26. 2022-03-28
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-12Pfizer-BioNTech
32021-09-27Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-01-12 priority 2/3

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-13

Systemic reaction (other): Supraclavicular and axillary painful lymphadenopathy

Release 9 — days 1–6 daily, dose 3

2021-09-29

Systemic reaction (other): Lymph node swelling

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…